Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » COVID-19 Response: From Panic to Complacency

    COVID-19 Response: From Panic to Complacency

    Antibody tests may become a big part of response in near term

    May 1, 2020
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    OSHA Enforcement Prioritizing Hazards Related to COVID-19 Response

    OSHA Enforcement Prioritizing Hazards Related to COVID-19 Response

    Related Products

    Nurses text, send images from the OR with new app

    25% of HCWs May Refuse to Treat Patients in Next Pandemic Threat

    Keywords

    anxiety

    tests

    COVID-19

    fauci

    distancing

    By: Gary Evans

    Even as the COVID-19 pandemic virus rages in some areas of the United States, there has been marked complacency in others, where public health pleas to stay at home and practice social distancing have been ignored by some.

    Karen Hoffmann, RN, MS, CIC, FSHEA, FAPIC, a clinical instructor of infectious diseases at the University of North Carolina’s School of Medicine in Chapel Hill, recalls the near-panic and fear during the emergence of AIDS in the 1980s.

    “With the COVID-19 outbreak in the U.S. population, it appears mixed messaging by media and federal agencies has led to a large percentage of the country not wanting to believe this is a real outbreak,” she says. “This resulted in a slow rate of compliance — or even open noncompliance — with social distancing and stay-at-home recommendations.”

    A ‘Super-Spreader’

    This is the result, in part, of a stealth aspect of the novel SARS-CoV-2 virus. It can spread from people who have mild illness or appear to be asymptomatic, yet still can cause severe disease and death in the elderly and those with underlying medical conditions. The Centers for Disease Control and Prevention (CDC) recently reported 16 COVID-19 cases that were transmitted in social gatherings.1

    “In this cluster, extended family gatherings, a birthday party, funeral, and church attendance, all of which occurred before major social distancing policies were implemented, might have facilitated transmission of SARS-CoV-2 beyond household contacts,” the CDC reported.

    In an example of the “super-spreader” phenomenon, the index patient apparently was able to transmit infection to 10 other persons, despite having only mild symptoms that did not require medical care.

    “Within three weeks after mild respiratory symptoms were noted in the index patient, 15 other persons were likely infected with SARS-CoV-2, including three who died,” the CDC reported.

    Given the stealth nature of the virus and the considerable chaos that has accompanied its emergence, it is perhaps not surprising that some people find it counterintuitive that they actually are in a pandemic, even as it accelerates in the United States — the nation that now has the highest number of COVID-19 cases in the world.

    There is even some level of complacency in healthcare workers in areas where there are few or no reported cases of COVID-19, says Hamad Husainy, DO, FACEP, an emergency physician at Helen Keller Hospital in Sheffield, AL.

    “I will say in general for our staff, it hasn’t become as real as it has in other parts of the country,” Husainy says. “They seem to be a little complacent, and I hope when this is all said and done they can look at me and say, ‘You were wound a little too tight.’”

    Given the lean stock of N95s, masks are worn over respirators that may be used indefinitely, he explained. “With regard to PPE [personal protective equipment] we really have not been well-prepared,” Husainy says. “We have literally two boxes of N95 masks in the entire hospital. We are being asked to take one and use it until further notice — until it gets visibly soiled or breaks or what have you. In dire circumstances, you do dire things.”

    The hospital plans to use powered air purifying respirators (PAPR) — which can be cleaned and reused — in the emergency department if suspected coronavirus cases begin presenting.

    “Right now, we are reserving them for the emergency medical staff,” he says. “In the ICU [intensive care unit], these patients have already been delineated as who is at risk and who is not. In the emergency room, people come in and you have to find that out. It’s a reality that we are going to run out of N95 respirators. My prediction is that our only option is going to be to use the PAPRs when we have to intubate somebody or place a patient on a ventilator.”

    Husainy urges his coworkers to remain on guard, reminding them that some healthcare workers were infected before there was recognized transmission in the community.

    In the early days of AIDS, a bloodborne disease, there were fears and speculation that it was spreading through the air or other means that were ultimately proven false. With no treatment, a diagnosis in those days was tantamount to a death sentence, and some healthcare workers died of needlesticks and other blood exposures.

    “A large percentage of all staff were panicked to have to care for these patients,” Hoffman says. “When they did enter the room, some wore all the PPE they could find — head covers, double gloves, masks, and booties. Although there was initial concern of respiratory transmission, that was quickly ruled out. However, the fear to care for the known or suspected AIDS patients carried on for years.”

    For the most part, healthcare personnel and the public have a healthy fear of COVID-19, but in some areas — exacerbated by mixed messages and a shortage of tests and PPE — the anxiety is at the early AIDS level.

    “Certainly, this has been more extensive than anything I can remember in terms of epidemics and epidemics of anxiety,” says William Schaffner, MD, professor of preventive medicine at Vanderbilt University. I think the concern and the anxiety resembles the introduction of HIV [in 1981] more than anything else that I can remember.”

    The Question of Immunity

    Part of the fear and anxiety is being driven by the unknowns, including definitive evidence that those infected will become immune for some time period.

    “That is certainly the hope,” Schaffner says. “If you look at the human coronaviruses — the ones that cause the common colds, you do get strain immunity — but it begins to wane fairly quickly after about a year. But that kind of immunity would be terribly important in blunting a resurgence of this virus in the fall. It might be a bridge to the time we can get a vaccine deployed.”

    Anthony Fauci, MD, director of the National Institutes of Health National Institute of Allergy and Infectious Diseases, also recently commented on this issue in a live-streamed interview with the Journal of the American Medical Association.

    “Right now, we don’t think that this [SARS-CoV-2] is mutating to the point of being very different,” Fauci said. “We are making a reasonable assumption that this virus is not changing very much. If you get infected in February and March — and then recover — that next September or October I believe that person is going to be protected. We are not 100% sure. But I think that is a reasonable assumption.”

    Antibody tests are now coming on the market that could detect if someone has generated an immune response to a prior COVID-19 infection.

    “There are a lot of companies trying to get them out, so they could be used for finger pricks with little devices and read within minutes,” Schaffner says. “This would be extraordinarily helpful in managing the healthcare and first responder environment. Then actually going out in communities and making an assessment about what proportion of the population is immune — it could help us get people with prior experience with the virus back to work.”

    These tests certainly have great promise to affect the coronavirus response, but the antibody diagnostics must be validated carefully before they are distributed widely, Fauci emphasized.

    “There have been international incidents where a country has ordered millions of these tests from another country — only to find that they don’t work,” he said. “We have to validate these tests — that’s absolutely critical, otherwise you will go down a path that will be very misleading.”

    In some sense, public health has been a victim of its own success, with antibiotics, vaccines, and antiviral therapies creating the illusion that the U.S. healthcare system was ready for any threat, Fauci said.

    “We let it slip, and boy, this should be a lesson for the future,” he said. “My hope is that when we get out of this — which we will — we will take a really good look at the long-term investments in the public health infrastructure. We should never again be in a position like this and have to scramble in response. This is historic. We all know the history of what happened in 1918, when we did not have hardly any of the interventions or the capabilities that we have now. You see what is happening in New York City, that is beyond sobering — that is really terrible.”

    REFERENCE

    1. Ghinai I, Woods S, Ritger KA, et al. Community transmission of SARS-CoV-2 at two family gatherings — Chicago, Illinois, February–March 2020. MMWR Morb Mortal Wkly Rep 2020; April 8. [Early release]. doi: http://dx.doi.org/10.15585/mmwr.mm6915e1

    Recent Articles by Gary Evans

    COVID-19 Mutations not Expected to Elude Vaccine

    Flu Vaccination Hesitancy in the Time of COVID-19

    Expert: Anti-Vaxxers Will Try to Undermine Pandemic Vaccine

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Hospital Infection Control & Prevention

    View PDF
    Hospital Infection Control & Prevention (Vol. 47, No. 5) - May 2020
    May 1, 2020

    Table Of Contents

    Personal Protective Equipment Shortage Is ‘Simply Unacceptable’

    The Forecast Calls for Pain

    COVID-19 Response: From Panic to Complacency

    Petition Demanding PPE for Healthcare Workers Has 1.7 Million Signatures

    C. difficile Infections Decrease in Hospitals, But Increase in Community

    OSHA Tells Inspectors to Use Discretion in Enforcing Respirator Fit-Testing

    Scientists Warn Pandemic May Not Decline in Warmer Weather

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Peer Reviewer Patrick Joseph, MD, reports that he is a consultant for Genomic Health, Siemens, and CareDx. Senior Writer Gary Evans, Editor Jason Schneider, Executive Editor Shelly Morrow Mark, Nurse Planner Patti Grant, RN, BSN, MS, CIC, Accreditations Director Amy M. Johnson, MSN, RN, CPN, and Editorial Group Manager Leslie Coplin report no consultant, stockholder, speaker’s bureau, research, or other financial relationships with companies having ties to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2021 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing